King Chuen Li from Emerald Hills, CA, age 68

Wikipedia References

King Li

Work:

Estimated dates of his reign are 877–841 BC or 857–842 BC ( " Cambridge History of Ancient China " ).

Skills & Activities:

Preference:

Exile

Medicine Doctors

Dr. King C Li, Winston Salem NC - MD (Doctor of Medicine)

view source

Specialties:

Diagnostic Radiology

Address:

1 Medical Center Blvd, Winston Salem, NC 27157
(336)7162255 (Phone), (336)7134216 (Fax)

6565 Fannin St Suite D280, Houston, TX 77030
(713)4414863 (Phone), (713)7937110 (Fax)

Wakeforest University Baptist Medical Center
1 Medical Center Blvd, Winston Salem, NC 27157
(336)7164667 (Phone)

Certifications:

Diagnostic Radiology

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

1 Medical Center Blvd, Winston Salem, NC 27157

6565 Fannin St Suite D280, Houston, TX 77030

Wakeforest University Baptist Medical Center
1 Medical Center Blvd, Winston Salem, NC 27157

The Methodist Hospital
6565 Fannin Street, Houston, TX 77030

Education:

Medical School
Toronto School of Medicine
Medical School
St Michaels Hosp
Medical School
U Toronto
Medical School
University Of Michigan Hospitals

King C. Li

view source

Specialties:

Radiology

Work:

Wake Forest School Of Medicine
Medical Ctr Blvd, Winston Salem, NC 27157
(336)7164316 (phone), (336)7161278 (fax)

Education:

Medical School
Univ of Toronto, Fac of Med, Toronto, Ont, Canada
Graduated: 1981

Languages:

English

Description:

Dr. Li graduated from the Univ of Toronto, Fac of Med, Toronto, Ont, Canada in 1981. He works in Winston-Salem, NC and specializes in Radiology. Dr. Li is affiliated with Novant Health Medical Park Hospital and Wake Forest Baptist Medical Center.

Resumes

King Li

view source

Location:

United States

License Records

King C Li

Address:

Dept Of Radiology & Nuclear Medicine Rm 1307, Stanford, CA

License #:

50783 - Expired

Category:

Health Care

Issued Date:

Jun 29, 1987

Effective Date:

Jan 1, 1901

Expiration Date:

Jan 31, 1998

Type:

Medical Doctor

Name / Title

Company / Classification

Phones & Addresses

King Li
Medical Doctor

Nih Clinical Center
Medical Laboratories

10 Center Dr 11 C, Bethesda, MD 20892

King Li
President

KIANCA INC
Whol Jewelry/Precious Stones · Jewelry Stores

101 Utah St STE 122, San Francisco, CA 94103
(415)8618188

Us Patents

Targeted Polymerized Liposome Diagnostic And Treatment Agents
view source
US Patent:

6350466, Feb 26, 2002
Filed:

Aug 29, 2000
Appl. No.:

09/650276
Inventors:

King Chuen Li - Stanford CA
Mark David Bednarski - Los Altos CA
Richard Wood Storrs - San Diego CA
Henry Y. Li - Visalia CA
Francois Daniel Tropper - Toronto, CA
Curtis Kang Hoon Song - Sunnyvale CA
Dorothy Anna Sipkins - Palo Alto CA
Jeremy Kenji Kuniyoshi - Cupertino CA
Assignee:

Targesome, Inc. - Palo Alto CA
International Classification:

A61K 9127
US Classification:

424450, 424 121, 424 9321, 424 951, 424 943, 424812, 436829, 935 54
Abstract:

Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Use Of Targeted Cross-Linked Nanoparticles For In Vivo Gene Delivery
view source
US Patent:

7514098, Apr 7, 2009
Filed:

May 30, 2002
Appl. No.:

10/159241
Inventors:

Mark D. Bednarski - Los Altos CA, US
Samira Guccione - Hillsborough CA, US
King Chuen Li - Bethesda MD, US
Assignee:

The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:

A61K 9/127
A61K 31/70
A01N 43/04
C12N 15/00
C12N 15/88
US Classification:

424450, 514 44, 435455, 435458
Abstract:

The in vivo delivery of nucleic acids is targeted by delivery of the nucleic acid in a complex with cross-linked nanoparticles; where the nanoparticles comprise cross-linked neutral amphipathic molecules, cationic amphipathic molecules and targeting amphipathic molecules. Optionally the cationic and targeting amphipathic molecules are also cross-linked. A targeting moiety present on the targeting amphipathic molecule provides for selective delivery of the complex to a predetermined target site, e. g. blood vessels, endothelial cells, tumor cells, liver cells, and the like.

Targeted Cross-Linked Nanoparticles And Their Use In Vivo Gene Delivery
view source
US Patent:

8163305, Apr 24, 2012
Filed:

Aug 20, 2008
Appl. No.:

12/195261
Inventors:

Mark D. Bednarski - Lushing MI, US
Samira Guccione - Hillsborough CA, US
King Chuen Li - Bethesda MD, US
Assignee:

The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:

A61K 9/127
A61K 31/70
A01N 43/04
C12N 15/00
C12N 15/88
US Classification:

424450, 435455, 435458, 514 44 R
Abstract:

The in vivo delivery of nucleic acids is targeted by delivery of the nucleic acid in a complex with cross-linked nanoparticles; where the nanoparticles comprise cross-linked neutral amphipathic molecules, cationic amphipathic molecules and targeting amphipathic molecules. Optionally the cationic and targeting amphipathic molecules are also cross-linked. A targeting moiety present on the targeting amphipathic molecule provides for selective delivery of the complex to a predetermined target site, e. g. blood vessels, endothelial cells, tumor cells, liver cells, and the like.

Use Of Polymerized Lipid Diagnostic Agents
view source
US Patent:

60904089, Jul 18, 2000
Filed:

Jul 27, 1998
Appl. No.:

9/122807
Inventors:

King Chuen Li - Stanford CA
Mark David Bednarski - Los Altos CA
Richard Wood Storrs - San Diego CA
Henry Y. Li - Visalia CA
Francois Daniel Tropper - Toronto, CA
Curtis Kang Hoon Song - Sunnyvale CA
Dorothy Anna Sipkins - Palo Alto CA
Jeremy Kenji Kuniyoshi - Cupertino CA
Assignee:

Targesome, Inc. - Palo Alto CA
International Classification:

A61K 9127
US Classification:

424450
Abstract:

Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Targeted Polymerized Liposome Contrast Agents
view source
US Patent:

55122949, Apr 30, 1996
Filed:

Aug 5, 1994
Appl. No.:

8/286555
Inventors:

King C. Li - Stanford CA
Mark D. Bednarski - Los Altos CA
Richard W. Storrs - Union City CA
Henry Y. Li - Visalia CA
Francois D. Trooper - Oakland CA
Curtis K. H. Song - Sunnyvale CA
Dorothy A. Sipkins - Palo Alto CA
Jeremy K. Kuniyoshi - Cupertino CA
International Classification:

A61K 9127
US Classification:

424450
Abstract:

Polymerized liposome particles based upon lipids having a polymerizable functional group and a metal chelator to attach an imaging enhancement agent and lipids having an active targeting group to provide targeted polymerized liposome contrast agents. The polymerized imaging enhancement liposome particles interact with receptor targets holding the image enhancement agent to specific sites providing in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology.

Targeted Polymerized Liposome Diagnostic And Treatment Agents
view source
US Patent:

61327646, Oct 17, 2000
Filed:

Apr 8, 1996
Appl. No.:

8/629056
Inventors:

King Chuen Li - Stanford CA
Mark David Bednarski - Los Altos CA
Richard Wood Storrs - San Diego CA
Henry Y. Li - Visalia CA
Francois Daniel Tropper - Toronto, CA
Curtis Kang Hoon Song - Sunnyvale CA
Dorothy Anna Sipkins - Palo Alto CA
Jeremy Kenji Kuniyoshi - Cupertino CA
Assignee:

Targesome, Inc. - Palo Alto CA
International Classification:

A61K 9127
US Classification:

424450
Abstract:

Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Enhancement Of Bioavailability By Use Of Focused Energy Delivery To A Target Tissue
view source
US Patent:

60661232, May 23, 2000
Filed:

Apr 9, 1998
Appl. No.:

9/057862
Inventors:

King Li - Stanford CA
Mark Bednarski - Los Altos CA
Assignee:

The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:

A61N 700
A61B 5055
A61K 9127
A61K 4800
US Classification:

604507
Abstract:

Targeted tissue in vivo is altered using focused energy to specifically control endothelial permeability and interstitial integrity. Image guidance may be used in combination with physical energy deposition to facilitate the targeted delivery of materials. The method of the invention serves as a platform for delivering pharmaceutical agents, nucleic acids, proteins, liposomes, etc. to cells.